Account
Inquiry
Tirzepatide 10mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently under investigation for type 2 diabetes treatment and weight management applications. Our tirzepatide 10mg formulation offers researchers high-quality material for preclinical studies and pharmaceutical development.
This synthetic peptide demonstrates superior efficacy in glucose control and weight reduction compared to selective GLP-1 receptor agonists. The molecular structure features PEG modification on the lysine side chain, enhancing water solubility while maintaining biological activity. Clinical trials have shown significant weight loss results, with the 10mg dose demonstrating 19.5% average weight reduction after 72 weeks in the SURMOUNT-1 study.
As a research chemical, tirzepatide 10mg represents an important tool for studying metabolic disorders. The compound's unique dual agonist mechanism provides valuable insights into GIP and GLP-1 receptor interactions. Researchers should note this product is for laboratory use only, not intended for human consumption.
Our tirzepatide 10mg is supplied as a white lyophilized powder with 99.9% purity, packaged in sterile vials under inert atmosphere to ensure stability. Each batch undergoes rigorous quality control testing including HPLC and mass spectrometry analysis to verify identity and purity.
Proper storage conditions are critical for maintaining peptide integrity. We recommend storing tirzepatide 10mg in a cool, dry environment protected from light. Avoid repeated freeze-thaw cycles and minimize exposure to air when handling. For long-term storage, maintain at -20°C or below.
Researchers investigating metabolic pathways, diabetes mechanisms, or obesity treatments will find tirzepatide 10mg an invaluable tool. The compound's unique pharmacological profile offers multiple avenues for scientific exploration in endocrinology and metabolic research.
